Home Support ISMP Newsletters Webinars Report Medication Error to ISMP Educational Resources ISMP Online Store Consulting Services FAQ Tools and Resources About ISMP Contact Us
Print This Page SitemapISMP Facebook
Site Search by PicoSearch. Help

TEXTBOOK AND PUBLICATION ERRATA

CORRECTION NOTICE - REMIFENTANIL HYDROCHLORIDE MONOGRAPH IN HANDBOOK ON INJECTABLE DRUGS, 15TH EDITION

(11/10/2009)

Remifentanil Hydrochloride Monograph
Y-Site Injection Compatibility Table, page 1411

The publishers of the Handbook on Injectable Drugs (HID), 15th edition, wish to inform you of an error in the monograph for Remifentanil Hydrochloride. In the third column from the left on page 1411 of the printed volume of HID 15th ed. next to the "Potassium Chloride" entry of the table, the concentration should be listed as "0.1 mEq/mL."

We urge you to correct this error in all copies of HID 15th ed. immediately and to communicate it to others on your staff who may use the book. 
For more information please visit: www.ashp.org/Import/NEWS/Corrections/CorrectionNotice-HID15ed.aspx.

 

Home | Contact UsEmployment  | Legal Notices | Privacy Policy | Help Support ISMP
  Med-ERRS |   ISMP Canada |  ISMP Spain | ISMP Brasil | International Group | Pennsylvania Patient Safety Authority

200 Lakeside Drive, Suite 200, Horsham, PA 19044, Phone: (215) 947-7797,  Fax: (215) 914-1492
© 2012 Institute for Safe Medication Practices. All rights reserved

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information: verify here.

Search only trustworthy HONcode health websites: